Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Na voljo sta dva načina iskanja: enostavno in napredno. Enostavno iskanje lahko zajema niz več besed iz naslova, povzetka, ključnih besed, celotnega besedila in avtorja, zaenkrat pa ne omogoča uporabe operatorjev iskanja. Napredno iskanje omogoča omejevanje števila rezultatov iskanja z vnosom iskalnih pojmov različnih kategorij v iskalna okna in uporabo logičnih operatorjev (IN, ALI ter IN NE). V rezultatih iskanja se izpišejo krajši zapisi podatkov o gradivu, ki vsebujejo različne povezave, ki omogočajo vpogled v podroben opis gradiva (povezava iz naslova) ali sprožijo novo iskanje (po avtorjih ali ključnih besedah).

Pomoč
Išči po:
Možnosti:
 


1931 - 1940 / 2000
Na začetekNa prejšnjo stran190191192193194195196197198199Na naslednjo stranNa konec
1931.
Novosti v neoadjuvantnem in adjuvantnem sistemskem zdravljenju kožnega melanoma
Martina Reberšek, 2025, objavljeni povzetek znanstvenega prispevka na konferenci

Ključne besede: melanom, kožni raki, kemoterapija
Objavljeno v DiRROS: 16.06.2025; Ogledov: 361; Prenosov: 229
.pdf Celotno besedilo (547,84 KB)
Gradivo ima več datotek! Več...

1932.
Kirurgija BCC in SCC
Barbara Perić, 2025, objavljeni povzetek znanstvenega prispevka na konferenci

Ključne besede: melanom, kožni raki, kirurgija
Objavljeno v DiRROS: 16.06.2025; Ogledov: 362; Prenosov: 251
.pdf Celotno besedilo (547,84 KB)
Gradivo ima več datotek! Več...

1933.
Sistemsko zdravljenje karcinoma Merklovih celic
Janja Ocvirk, 2025, objavljeni povzetek znanstvenega prispevka na konferenci

Ključne besede: melanom, kožni raki, kemoterapija
Objavljeno v DiRROS: 16.06.2025; Ogledov: 416; Prenosov: 237
.pdf Celotno besedilo (547,84 KB)
Gradivo ima več datotek! Več...

1934.
Sistemsko zdravljenje bazalnoceličnega karcinoma kože (BCC)
Janja Ocvirk, 2025, objavljeni povzetek znanstvenega prispevka na konferenci

Ključne besede: melanom, kožni raki, kemoterapija
Objavljeno v DiRROS: 16.06.2025; Ogledov: 337; Prenosov: 196
.pdf Celotno besedilo (547,84 KB)
Gradivo ima več datotek! Več...

1935.
Sistemsko zdravljenje napredovalega melanoma
Janja Ocvirk, 2025, objavljeni povzetek znanstvenega prispevka na konferenci

Ključne besede: melanom, kožni raki, kemoterapija
Objavljeno v DiRROS: 16.06.2025; Ogledov: 500; Prenosov: 230
.pdf Celotno besedilo (547,84 KB)
Gradivo ima več datotek! Več...

1936.
Sistemsko onkološko zdravljenje SCC
Tanja Mesti, 2025, objavljeni povzetek znanstvenega prispevka na konferenci

Ključne besede: melanom, kožni raki, kemoterapija
Objavljeno v DiRROS: 16.06.2025; Ogledov: 423; Prenosov: 229
.pdf Celotno besedilo (547,84 KB)
Gradivo ima več datotek! Več...

1937.
Pot bolnika do onkologa
Tanja Mesti, 2025, objavljeni povzetek znanstvenega prispevka na konferenci

Ključne besede: melanom, kožni raki, kemoterapija
Objavljeno v DiRROS: 16.06.2025; Ogledov: 385; Prenosov: 222
.pdf Celotno besedilo (547,84 KB)
Gradivo ima več datotek! Več...

1938.
Alkali-activated artificial aggregates
Anže Tesovnik, Ottosen Lisbeth M., Vilma Ducman, 2025, zaključena znanstvena zbirka raziskovalnih podatkov

Povzetek: The dataset file contains measurements from macro- to micro-scale analyses of alkali-activated aggregates produced from biomass fly ash. It includes data on mechanical performance, microstructural characterization, and chemical and mineralogical composition. This dataset supports the findings presented in the article entitled "Carbonation of lightweight alkali-activated aggregates based on biomass fly ash: effect on microstructure and leaching behavior" (https://doi.org/10.1016/j.cscm.2025.e05014).
Ključne besede: measurements, alkali-activated materials, biomass ash, carbonation, artificial aggregates
Objavljeno v DiRROS: 16.06.2025; Ogledov: 585; Prenosov: 345
.xlsx Raziskovalni podatki (478,07 KB)
Gradivo ima več datotek! Več...

1939.
Remission of chronic urticaria in patients treated with omalizumab
Klara Cvenkel, Mojca Bizjak, Julij Šelb, Mitja Košnik, 2024, izvirni znanstveni članek

Povzetek: Introduction: This study examined the remission probability and duration in chronic spontaneous urticaria (CSU) patients resistant to second-generation H1-antihistamines (sgAHs) undergoing omalizumab treatment. Methods: This is a retrospective observational study of 176 adult CSU patients exhibiting a significant pruritus component (≥ 8) of the weekly urticaria activity score (UAS7) despite four daily sgAH tablets and starting omalizumab treatment with 300 mg every 4 weeks. After excluding 13 nonresponders, we analyzed 163 omalizumab responders (mean age 51.8 years, 74.4% female). The intervals between applications were increased. Discontinuation was considered for patients that remained asymptomatic on a gradually reduced dosage (to 150 mg every 12 weeks) without sgAHs. Results: Omalizumab discontinuation was possible in 25.8% (42/163). The duration of omalizumab treatment before remission ranged from 7 to 6 months. Twenty-one patients (50.0%) maintained complete remission until the end of the observation period (September 2021) for 8 to 68 months. Of the relapsed patients, 71.4% (15/21) effectively controlled CSU with sgAHs. Six patients (28.6%; 6/21) required omalizumab reintroduction after 6 to 40 months of remission, responding favorably. Conclusions: The study shows that a quarter of severe CSU patients achieve long-term remission. In addition, sgAHs effectively manage symptoms in a majority of relapsed cases, and those requiring omalizumab reintroduction respond favorably.
Ključne besede: urticaria, antihistamines, omalizumab, urticaria, remission, urticaria relapse
Objavljeno v DiRROS: 16.06.2025; Ogledov: 409; Prenosov: 237
.pdf Celotno besedilo (537,92 KB)
Gradivo ima več datotek! Več...

1940.
High-Intensity Fast-Response Electric Radiant Panel (HIFREP) to impose fire equivalent heat fluxes on building elements with enhanced thermal boundary conditions accuracy
Florian Put, Balša Jovanović, Evelien Symoens, Andrea Lucherini, Bart Merci, Ruben Van Coile, 2025, izvirni znanstveni članek

Povzetek: Bench-scale fire testing has gained popularity as a highly controllable and cost-effective solution, overcoming many of the shortcomings of traditional large-scale fire resistance tests. Whereas gas-fired radiant panels have demonstrated significant success in this area, the present study introduces a novel High-Intensity Fast-Response Electric radiant Panel (HIFREP). Utilizing electrically operated radiation emitters, it provides more precise and quasi-instantaneous control over the thermal boundary conditions. HIFREP delivers high and stable heat fluxes up to 105 kW/m2 , and, due to the low thermal inertia of the emitters, can rapidly adjust its output to changes in the input. In this regard, the time constant of the emitters has been found to be less than 1 s, both during heating and cooling. It eliminates gas combustion and hence avoids the need for extraction hoods when testing the fire performance of non-combustible materials, making it suitable for traditional structural testing laboratories. The presented High-Intensity Fast-Response Electric radiant Panel also provides a reliable tool for the validation of FEM simulation results by accurately replicating the thermal boundary conditions in structural fire engineering analyses.
Ključne besede: radiant panel, fire testing, heat transfer, radiation, heat flux, thermal boundary conditions
Objavljeno v DiRROS: 16.06.2025; Ogledov: 403; Prenosov: 84
.pdf Celotno besedilo (1,98 MB)
Gradivo ima več datotek! Več...

Iskanje izvedeno v 0.71 sek.
Na vrh